Woofun AI reports that Terrence Duffy, CEO of CME Group, has disclosed the exchange's intention to initiate legal proceedings against the U.S. Commodity Futures Trading Commission (CFTC). The dispute centers on the regulatory classification of perpetual contracts, with Duffy asserting that the Dodd-Frank Act categorizes these instruments as swap contracts.

Duffy emphasized that CME Group holds exclusive licensing agreements with key benchmark providers, mandating that all related products be traded exclusively on the CME platform. Should the court uphold this interpretation, the CFTC would be compelled to formally list these perpetual contracts as swaps, thereby reinforcing CME's market dominance in this asset class.